What is Alessa Therapeutics worth?
$49.0Mlast known valuation
Alessa Therapeutics last raised $25.4M in its Early Stage VC (Apr 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Alessa Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2025 | Early Stage VC | $25.4M | ▮ | ▮ |
| Dec 2019 | Seed Round | $3.3M | ▮ | ▮ |
| Mar 2019 | Seed Round | $3.0M | ▮ | ▮ |
How Alessa Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Alessa Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Alessa Therapeutics worth?
- Alessa Therapeutics's last known valuation is $49.0M.
- How much has Alessa Therapeutics raised?
- Alessa Therapeutics has raised $31.6M in total funding across 3 recorded rounds.
- When did Alessa Therapeutics last raise?
- Alessa Therapeutics last raised in Apr 2025 (Early Stage VC), raising $25.4M.